Literature DB >> 4679879

A comparison of in vitro and in vivo solute-protein binding interactions in normal and uremic subjects.

P C Farrell, N L Grib, D L Fry, R P Popovich, J W Broviac, A L Babb.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4679879     DOI： 10.1097/00002480-197201000-00067

Source DB:  PubMed          Journal:  Trans Am Soc Artif Intern Organs        ISSN： 0066-0078


× No keyword cloud information.
  12 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.

Authors:  I Odar-Cederlof
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

Review 3.  Factors influencing drug protein binding in patients with end stage renal failure.

Authors:  R Vanholder; R De Smet; S Ringoir
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

Review 5.  The binding of drugs to plasma proteins from patients with poor renal function.

Authors:  M M Reidenberg
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Sorption kinetics in haemoperfusion columns. Part 1: estimation of mass-transfer parameters.

Authors:  D F Radcliffe; J D Gaylor
Journal:  Med Biol Eng Comput       Date:  1981-09       Impact factor: 2.602

Review 7.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 8.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 9.  The effect of chronic renal failure on drug metabolism and transport.

Authors:  Albert W Dreisbach; Juan J L Lertora
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-08       Impact factor: 4.481

Review 10.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.